大家健康(中旬版)
大傢健康(中旬版)
대가건강(중순판)
GOOD HEALTH FOR ALL
2014年
3期
18-18
,共1页
开腹术%腹腔镜术%子宫鳞癌%治疗%观察
開腹術%腹腔鏡術%子宮鱗癌%治療%觀察
개복술%복강경술%자궁린암%치료%관찰
treatedlaparotomy laparoscopicuterinecarcinoma
目的:分析子宫颈癌采用根治术治疗后未控及复发的临床观察,并对其治疗效果进行分析。方法:将我院60例患有根治术后未控及复发子宫颈癌的患者随机分为两组,分别是观察组与对照组,每组30例,对照组采用5-氟脲嘧啶联合顺铂治疗,观察组采用开普拓治疗,对其复发疗效及不良反应进行分析。结果:观察组总有效率66.67%;对照组总有效率36.67%,各项统计均具有统计学意义(P<0.05);观察组患者常见不良反应为腹泻、恶心呕吐和脱发,两组患者生活质量均得到改善。结论:开普拓治疗子宫颈癌根治术后未控及复发效果明显优于5-氟脲嘧啶联合顺铂的治疗,值得临床广泛推广。
目的:分析子宮頸癌採用根治術治療後未控及複髮的臨床觀察,併對其治療效果進行分析。方法:將我院60例患有根治術後未控及複髮子宮頸癌的患者隨機分為兩組,分彆是觀察組與對照組,每組30例,對照組採用5-氟脲嘧啶聯閤順鉑治療,觀察組採用開普拓治療,對其複髮療效及不良反應進行分析。結果:觀察組總有效率66.67%;對照組總有效率36.67%,各項統計均具有統計學意義(P<0.05);觀察組患者常見不良反應為腹瀉、噁心嘔吐和脫髮,兩組患者生活質量均得到改善。結論:開普拓治療子宮頸癌根治術後未控及複髮效果明顯優于5-氟脲嘧啶聯閤順鉑的治療,值得臨床廣汎推廣。
목적:분석자궁경암채용근치술치료후미공급복발적림상관찰,병대기치료효과진행분석。방법:장아원60례환유근치술후미공급복발자궁경암적환자수궤분위량조,분별시관찰조여대조조,매조30례,대조조채용5-불뇨밀정연합순박치료,관찰조채용개보탁치료,대기복발료효급불량반응진행분석。결과:관찰조총유효솔66.67%;대조조총유효솔36.67%,각항통계균구유통계학의의(P<0.05);관찰조환자상견불량반응위복사、악심구토화탈발,량조환자생활질량균득도개선。결론:개보탁치료자궁경암근치술후미공급복발효과명현우우5-불뇨밀정연합순박적치료,치득림상엄범추엄。
Objective :To observe the clinical analysis of cervical canceris not controlled by radical surgery treatment and relapse ,and thetreatment effect was analyzed .Methods :60 patients in our hospital were randomly divided with uncontrolled after radical surgeryand recurrenceof cervical cancer-into two groups ,respectively is the observation group and control group ,30 cases in each group ,the control group using 5 -fluorouracil and cisplatin-treatment ,observation group with CPT -11 treatment ,and the adverse effect ofthe therapeutic effect of analysis .Results:in the observation group , the total efficiency of 66 .67% ;control group ,the total efficiency of 36 .67% ,all the statisticshad statistical significance (P<0 .05);the patients in the observation group were the common adverse reactions were diarrhea ,nausea and vomiting and hair loss ,two groups of patients quality of life were im-proved .Conclusion:the treatment ofcampto uncontrolledradical treatment of cervical cancer recurrence aftereffect is obviously better than that of 5 -fluorouracil and cisplatin ,is worthy of clinical application .